Hypofractionated external-beam radiation therapy (HEBRT) versus conventional external-beam radiation (CEBRT) in patients with localized prostate cancer: a systematic review and meta-analysis.
Tobias Engel Ayer BotrelOtávio ClarkAntônio Carlos Lima PompeoFrancisco Flávio Horta BretasMarcus Vinicius SadiUbirajara FerreiraRodolfo Borges Dos ReisPublished in: Core evidence (2013)
Hypofractionated radiotherapy in localized prostate cancer was not superior to conventional radiotherapy and showed higher acute gastrointestinal toxicity in this meta-analysis. Because the number of published studies is still small, future assessments should be conducted to clarify better the true role of hypofractionated radiotherapy in patients with prostate cancer.